Life Care Medical Devices Ltd Announces Addition Of Dublin, Ireland Based European Subsidiary
NEW YORK, May 10, 2013 /PRNewswire/ -- Life Care Medical Devices Ltd (OTCBB:LCMD) today announced the opening of their European subsidiary offices in Dublin, Ireland. Life Care Medical Devices Ltd, Ireland will manage all aspects of the company's European business.
"With a strong, solid history in the medical device arena, Ireland, and Dublin specifically, was a logical choice for the European Base of operations," said Glenn Foley, Chief Executive Officer of Life Care Medical Devices Ltd. (LCMD). "We believe that this will be the best location for LCMD to provide service and support to the large, and important European markets."
Additionally, the Board of Directors of LCMD have named Glenn Foley, Managing Director of Life Care Medical Devices Ltd, Ireland.
Life Care Medical Devices Ltd is an ISO 13485 certified manufacturer of medical devices. LCMD's focus is on underserved aspects of large medical sub segments such as laparoscopic surgery and pain management. LCMD 's portfolio of proprietary and patent in process devices address clinical needs in these markets through innovative product design, development, and delivery to the medical market.
Please Note: This release may contain forward-looking statements regarding our prospective performance. Forward-looking statements are based on certain assumptions and describe future plans, strategies, and expectations of our company. Accordingly, actual results may differ materially from anticipated results. Some of the factors that could cause our actual results to differ from our expectations include, without limitation: the unpredictability of the size of the markets for, and market acceptance of, any of our products, including the Keyhole Cup Laparoscopic Access Device; our ability to produce and sell any approved products and the price we are able realize for those products; our ability to enter into and maintain collaborations with third parties for the development and commercialization of our products, including the Keyhole Cup Laparoscopic Access Device; our need to obtain additional funding and our ability to obtain future funding on acceptable terms; our ability to retain and hire necessary employees and to staff our operations appropriately; and our dependence on the success of the Keyhole Cup Laparoscopic Access Device. The reader is referred to the documents that we file from time to time with the Securities and Exchange Commission.
SOURCE Life Care Medical Devices Ltd